Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Free Fatty Acid Receptor 4 - Pipeline Review, H2 2016 Featuring Advinus Therapeutics, Dompe Farmaceutici, GSK & Sancilio & Company - Research and Markets

Research and Markets
Posted on: 13 Oct 16

Research and Markets has announced the addition of the "Free Fatty Acid Receptor 4 - Pipeline Review, H2 2016" report to their offering.

Free Fatty Acid Receptor 4 pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies.

Free Fatty Acid Receptor 4 is a G protein-coupled receptor (GPR) encoded by FFAR4 gene. It acts as receptor for medium and long-chain free fatty acids (FFAs). It acts as a receptor for omega-3 fatty acids and mediates robust anti-inflammatory effects, particularly in macrophages and fat cells. The anti-inflammatory effects involve inhibition of TAK1 through a beta-arrestin 2 (ARRB2)/TAB1-dependent effect, but independent of the G (q)/G (11)-coupled pathway. It mediates potent insulin sensitizing and antidiabetic effects by repressing macrophage-induced tissue inflammation. It mediates the taste of fatty acids.

The report 'Free Fatty Acid Receptor 4 - Pipeline Review, H2 2016' outlays comprehensive information on the Free Fatty Acid Receptor 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Free Fatty Acid Receptor 4 targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Currently, The molecules developed by Companies in Preclinical and Discovery stages are 1 and 4 respectively.

Key Topics Covered:

  1. Introduction
  2. Free Fatty Acid Receptor 4 Overview
  3. Therapeutics Development
  4. Pipeline Products for Free Fatty Acid Receptor 4 - Overview
  5. Pipeline Products for Free Fatty Acid Receptor 4 - Comparative Analysis
  6. Free Fatty Acid Receptor 4 - Therapeutics under Development by Companies
  7. Free Fatty Acid Receptor 4 - Therapeutics under Investigation by Universities/Institutes
  8. Free Fatty Acid Receptor 4 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Free Fatty Acid Receptor 4 - Products under Development by Companies
  13. Free Fatty Acid Receptor 4 - Products under Investigation by Universities/Institutes
  14. Free Fatty Acid Receptor 4 - Companies Involved in Therapeutics Development
  • Advinus Therapeutics Ltd
  • Dompe Farmaceutici S.p.A.
  • GlaxoSmithKline Plc
  • Sancilio & Company, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/75psp3/free_fatty_acid

View source version on businesswire.com: http://www.businesswire.com/news/home/20161013005941/en/

Business Wire
www.businesswire.com

Last updated on: 13/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.